<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03838458</url>
  </required_header>
  <id_info>
    <org_study_id>Hypospadic prepuce structure</org_study_id>
    <nct_id>NCT03838458</nct_id>
  </id_info>
  <brief_title>Molecular and Structural Comparison of Hypospadic and Normal Children Prepuces</brief_title>
  <official_title>Comparison of Structural and Molecular Genetic Properties Between Normal and Hypospadic Children's Prepuces</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Trakya University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Trakya University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare prepuce tissue samples from healthy male children who
      applied for circumcision and children with isolated hypospadias. Estrogen receptor 1 (ER1),
      androgen receptor (AR), FGFR2, transforming growth factor beta (TGF beta) and HOXA13 gene
      expression in the prepuce is planned to investigate via polymerase chain reaction (PCR)
      method. Mucosal vascular and nerve densities, and extracellular matrix density of laminin and
      collagen protein is planned to investigate via immunohistochemical examination.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 7, 2019</start_date>
  <completion_date type="Actual">March 10, 2020</completion_date>
  <primary_completion_date type="Actual">January 7, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Genetic analysis 1</measure>
    <time_frame>1 year</time_frame>
    <description>Androgen receptor (AR) gene PCR analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Genetic analysis 2</measure>
    <time_frame>1 year</time_frame>
    <description>Estrogen receptor 1 (ER1) gene PCR analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Genetic analysis 3</measure>
    <time_frame>1 year</time_frame>
    <description>FGFR2 gene PCR analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Genetic analysis 4</measure>
    <time_frame>1 year</time_frame>
    <description>TGF beta gene PCR analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Genetic analysis 5</measure>
    <time_frame>1 year</time_frame>
    <description>HOXA13 gene PCR analysis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Immunohistochemical study 1</measure>
    <time_frame>1 year</time_frame>
    <description>Mucosal vessel density is planned to determine via CD34</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Immunohistochemical study 2</measure>
    <time_frame>1 year</time_frame>
    <description>Mucosal nerve density is planned to determine via PGP 9.5</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Histological study 1</measure>
    <time_frame>1 year</time_frame>
    <description>Laminin is planned to determine in extracellular matrix via light microscope</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Histological study 2</measure>
    <time_frame>1 year</time_frame>
    <description>Collagen is planned to determine in extracellular matrix via light microscope</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">52</enrollment>
  <condition>Hypospadias</condition>
  <arm_group>
    <arm_group_label>Study</arm_group_label>
    <description>Children with isolated hypospadias</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <description>Children with planned circumcision</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Preputial tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        0-18 years old pediatric male population, patients with isolated hypospadias are study
        group, patients with planned circumcision are control group.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  To apply for circumcision, not to have any genitourinary abnormalities/conditions for
             control group.

          -  To have isolated hypospadias for study group.

        Exclusion Criteria:

          -  To have genitourinary surgery before.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dincer Avlan, Profesor, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Trakya University Faculty of Medicine, Pediatric Surgery Department</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Trakya University Faculty of Medicine</name>
      <address>
        <city>Edirne</city>
        <zip>22030</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>February 8, 2019</study_first_submitted>
  <study_first_submitted_qc>February 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 12, 2019</study_first_posted>
  <last_update_submitted>April 25, 2020</last_update_submitted>
  <last_update_submitted_qc>April 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Trakya University</investigator_affiliation>
    <investigator_full_name>Irem Inanc</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>hypospadias</keyword>
  <keyword>prepuce</keyword>
  <keyword>HOXA13</keyword>
  <keyword>FGFR2</keyword>
  <keyword>TGF beta</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypospadias</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

